# Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis

> **NCT02131077** · PHASE1,PHASE2 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Tennis Elbow

## Interventions

- **BIOLOGICAL:** ALLO-ASC-TI
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02131077
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2014-10
- **Final completion:** 2015-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02131077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02131077, "Safety and Efficacy Study of Allogeneic Adipose-derived Stem Cells for Treatment of Lateral Epicondylitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02131077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*